EvaluatIon of Autologous Nucleus Pulposus Cells (aNPC) in Degenerative Disc Disease

NCT07168603 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Intervertebral Disc Degeneration

Interventions

DRUG: aNPC

Sponsor

ASTEROGENE Biomedical Co. Ltd.